Published 1 day ago • loading... • Updated 7 hours ago

Boston drug doubles survival in pancreatic cancer trial

Summary by WCVB

A Boston-developed pill has earned FDA approval for pancreatic cancer, offering new hope after a trial showed patients lived longer.

5 Articles

WMUR

Center

Dartmouth patients among first to get new drug that fights pancreatic cancer

A new drug has nearly doubled the survival rate for people suffering from pancreatic cancer, and doctors say it might be able to treat other types of cancer, as well.

7 hours ago·Manchester, United States

Read Full Article

telex.hu

Lean Left

Cancer Drug so Effective It Received a Standing Ovation at an Oncology Conference Has Been Approved in America

The new drug has doubled the survival time of pancreatic cancer patients, according to research.

12 hours ago

Read Full Article

Globo

Lean Right

How Does the Drug that Doubles the Lifespan of People with Newly Approved Advanced Pancreatic Cancer Work in the Body?

The Food and Drug Administration (FDA), a public health regulatory agency in the United States, approved on Wednesday (26) a new medicine for advanced pancreatic cancer, inaugurating a new era in the treatment of a disease that has long been considered one of the most desperate in medicine. Asphyxiation in 35 minutes, hypothermia: what can a torrent of mud like Nepal cause in the human body? Lito Sousa: what is and how does Home Care for Creutzf…

20 hours ago·Rio de Janeiro, Brazil

Read Full Article